3rd Quarter - Report

BAY BRIDGE STRATEGIES, INC. for BIOCRYST PHARMACEUTICALS, INC.

Period 3rd Quarter 2017 Filed Oct 20, 2017 Signed by Alix Burns, President

Official filing
Firm
BAY BRIDGE STRATEGIES, INC.
Client
BIOCRYST PHARMACEUTICALS, INC.
Income
$20,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

Issues related to funding for disease research and pandemic preparedness. Issues related to appropriations for pandemic preparedness. H.R. 3358/S. 1771 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018.

LobbyistCovered position, as disclosed
ALEXANDRA BURNS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3358 (115th), S. 1771 (115th)

Disaster Planning/Emergencies DIS

Issues related to funding for disease research and pandemic preparedness. Issues related to appropriations for pandemic preparedness. H.R. 3358/S. 1771 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018.

LobbyistCovered position, as disclosed
ALEXANDRA BURNS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3358 (115th), S. 1771 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.